The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Afshar, R.
Right arrow Articles by Oltz, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Afshar, R.
Right arrow Articles by Oltz, E. M.
The Journal of Immunology, 2006, 176: 2439-2447.
Copyright © 2006 by The American Association of Immunologists

Regulation of IgH Gene Assembly: Role of the Intronic Enhancer and 5'DQ52 Region in Targeting DHJH Recombination1

Roshi Afshar*, Steven Pierce*, Daniel J. Bolland{dagger}, Anne Corcoran{dagger} and Eugene M. Oltz2,*

* Department of Microbiology/Immunology, Vanderbilt University Medical School, Nashville, TN 37232; and {dagger} Laboratory of Chromatin and Gene Expression, The Babraham Institute, Babraham, Cambridge, United Kingdom


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
The assembly of Ag receptor genes by V(D)J recombination is regulated by transcriptional promoters and enhancers which control chromatin accessibility at Ig and TCR gene segments to the RAG-1/RAG-2 recombinase complex. Paradoxically, germline deletions of the IgH enhancer (Eµ) only modestly reduce DH->JH rearrangements when assessed in peripheral B cells. However, deletion of Eµ severely impairs recombination of VH gene segments, which are located over 100 kb away. We now test two alternative explanations for the minimal effect of Eµ deletions on primary DH->JH rearrangement: 1) Accessibility at the DHJH cluster is controlled by a redundant cis-element in the absence of Eµ. One candidate for this element lies 5' to DQ52 (PDQ52) and exhibits promoter/enhancer activity in pre-B cells. 2) In contrast to endpoint B cells, DH->JH recombination may be significantly impaired in pro-B cells from enhancer-deficient mice. To elucidate the roles of PDQ52 and Eµ in the regulation of IgH locus accessibility, we generated mice with targeted deletions of these elements. We report that the defined PDQ52 promoter is dispensable for germline transcription and recombination of the DHJH cluster. In contrast, we demonstrate that Eµ directly regulates accessibility of the DHJH region. These findings reveal a significant role for Eµ in the control mechanisms that activate IgH gene assembly and suggest that impaired VH->DHJH rearrangement in enhancer-deficient cells may be a downstream consequence of the primary block in DH->JH recombination.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
The enormous diversity of Ag receptors required for mammalian immunity is generated in precursor lymphocytes by a genetic process, termed V(D)J recombination. Each precursor lymphocyte assembles unique Ig or TCR genes via the random selection of one variable (V), one diversity (D), and one joining (J) gene segment from large arrays of these elements (1, 2, 3, 4). Each of these recombination events is mediated by a single enzyme complex that contains the lymphocyte-specific proteins RAG-1 and RAG-2 (5, 6). The RAG-1/2 complex binds to conserved DNA elements, termed recombination signal sequences (RSSs),3 which flank all V, D, and J segments (1, 7). Following the synapsis of two compatible RSSs, the RAG proteins introduce dsDNA breaks precisely at the RSS/coding region borders, resulting in a pair of coding and signal ends. Subsequently, the coding and signal ends are ligated by ubiquitous double-strand break repair machinery to produce chromosomal coding joins and signal joins, which are normally deleted as an extrachromosomal circle (1, 2, 8).

Although all Ag receptor loci use a common RAG complex and RSS substrates for their assembly, V(D)J recombination is regulated by stage-, allele- and tissue-specific mechanisms. For example, Ig genes rearrange efficiently in precursor B cells, whereas TCR genes remain frozen in their germline configuration (4). The process of Ig gene assembly is also highly ordered, initiating at the pro-B cell stage with recombination between 1 of 13 DH gene segments and 1 of 4 JH segments. Subsequent recombination between a preformed DHJH element and 1 of ~150 VH gene segments completes the assembly of an Ig V region exon (9, 10, 11). Productive rearrangement of an IgH allele by a pro-B cell stimulates progression of that clone to the pre-B cell stage, blocks further VH->DHJH recombination (allelic exclusion), and signals for initiation of IgL chain gene assembly (9, 10). In-frame rearrangement of an IgL chain gene (Ig{kappa} or Ig{lambda}) enables the precursor cell to express its signature BCR and to differentiate into a naive B cell clone (9).

The tissue- and stage-specific aspects of V(D)J recombination are largely controlled by changes in the accessibility of chromatin at targeted gene segments (12). Recombinationally active gene segments are generally transcribed, reflecting an open chromatin configuration that is accessible to both V(D)J recombinase and the transcriptional machinery (13, 14, 15, 16, 17). Indeed, cis-acting elements that potentiate the transcription of Ig and TCR genes also regulate the accessibility of gene segments to recombinase. Deletion of transcriptional enhancers from the TCR{alpha}, TCRbeta, or the Ig{kappa} loci significantly reduces both germline transcription and recombination of gene segments in cis- (18, 19, 20, 21). Likewise, deletion of a germline promoter associated with the Dbeta1 gene segment severely impairs Dbeta1->Jbeta recombination in thymocytes or in model recombination substrates (22, 23). One apparent exception to enhancer-mediated control of recombinase accessibility was thought to be the IgH locus. Deletion of the only known enhancer near the DHJH region, termed the IgH intronic enhancer (Eµ), only modestly reduced DH->JH rearrangements detected in peripheral B cells (24, 25). In contrast, VH->DHJH recombination was severely compromised at the mutant allele.

Two potential explanations have emerged for the minimal effects of Eµ deletions on DH->JH recombination. First, prior analyses were performed on splenic B cells that were heterozygous for the mutant IgH allele (Eµ+/–) (25). These analyses cannot exclude the possibility that Eµ exerts a more profound effect on recombinase accessibility at the DHJH cluster in pro-B cells. Low levels of DH->JH recombination at the mutant allele would continue throughout differentiation to the mature B cell stage following productive IgH assembly at the wild-type (WT) allele. Allelic exclusion would effectively block VH->DHJH recombination at the mutant allele in all stages subsequent to pro-B cells. These accumulated DHJH rearrangements in mature B cells would, therefore, mask the true effects of the Eµ knockout on DH->JH recombination. Alternatively, a partially redundant element may exist in the DHJH cluster, which could synergize with Eµ to regulate recombinase accessibility. An attractive candidate for this additional element lies adjacent to the most proximal DH gene segment, termed DQ52 (see Fig. 1A). This element, termed PDQ52, exhibits promoter and enhancer activity in pre-B cell models (26). Moreover, PDQ52 and Eµ colocalize with the only two DNase I hypersensitive sites detected in the DHJH cluster of precursor B cells (27). In prior studies, deletion of the DQ52 gene segment and a small portion of PDQ52 had no effect on overall levels of DH->JH recombination. Instead, this deletion reduced levels of rearrangements that specifically involved the JH3 and JH4 segments (28). Given the architecture of the knockout, however, these studies could not directly address the role of PDQ52 in directing efficient IgH recombination.


Figure 1
View larger version (35K):
[in this window]
[in a new window]
 
FIGURE 1. Targeted mutation of the PDQ52 and Eµ elements. A, Schematic depiction of WT and mutant IgH loci generated by homologous recombination (not drawn to scale). Diagrams illustrate the relative positions of the PDQ52 promoter region, the DQ52 and JH gene segments, the intronic enhancer (Eµ), the switch µ region (Iµ-Sµ), and the IgM constant region exons (Cµ). Also indicated are BamHI (B) restriction sites, the relative location of probes A and B used in Southern blotting analysis (B), and the PGK-Neo cassette flanked by loxP sites (triangles). Predicted sizes for BamHI restriction fragments relevant to Southern blotting analysis (B) are shown are thick bars below each schematic. B, Genotypic analysis of mice harboring germline IgH mutations. Southern blotting was performed on BamHI digested tail DNA from mice corresponding to the indicated genotypes (+, WT; N, Neo-containing allele; {Delta}, Neo-deleted allele). The genomic Southern blots were hybridized to either probe A (left panel) or probe B (right panel). Sizes of the restriction fragments are indicated at the left of each panel.

 
To define the roles of Eµ and PDQ52 in IgH gene assembly, we generated mice lacking one or both of these elements. We find that germline transcription and rearrangement of IgH gene segments are unaffected by deletion of PDQ52. In contrast, deletion of both PDQ52 and Eµ nearly abrogates transcription of the germline DHJH cluster. This dual deletion, or mutation of the core Eµ element alone, dramatically reduced DH->JH rearrangement in bone marrow pro-B cells and thymocytes. Based on these findings, we conclude that Eµ is an important cis-acting element involved in the control of recombinase accessibility at DHJH gene segments and is required for the efficient initiation of IgH gene assembly.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Knockout mice

Two targeting vectors were prepared to delete either PDQ52 alone (PE+) or PDQ52 in combination with the 700-bp EcoRI/Xba fragment spanning Eµ and its 5' matrix attachment region (MAR) (PE; see Fig. 1A). Both targeting vectors were cloned into pBluescript (Stratagene) containing a thymidine kinase gene driven by the PGK promoter. The vectors were linearized with NotI in the polylinker region flanking the 5' homology sequences. The promoter deletion in the PE construct was generated using PCR by replacing 300-bp upstream of the 5' DQ52-RSS with a NotI site. A PGK-Neo cassette flanked by two loxP sites was cloned into the NotI site. The 5' homology arm of each vector was derived from C57BL/6 genomic sequences and spanned 6.3 kb upstream of the PDQ52 deletion. The 3' homology arm contained DQ52, the JH cluster, and an additional 1.8 kb of sequences 3' to the Eµ deletion. The PE+ construct lacked an additional 200 bp of 5' DQ52 sequences spanning a cluster of XbaI sites that were positioned 600 bp upstream of the PDQ52 deletion.

Embryonic stem (ES) cells were grown on mouse embryonic fibroblasts and transfected with linearized targeting vectors as described previously (29). Potential recombinants were screened by PCR assays specific for the mutant IgH alleles. All PCR-positive clones were analyzed by Southern blotting to confirm homologous integration of the vectors. Chimeric mice generated from targeted ES cells were mated with C57BL/6 females and germline transmission of the mutated allele was verified by Southern blotting analysis of tail DNA from F1 offspring (see Fig. 1). The floxed Neo cassette was deleted from targeted alleles by crossing the mutant animals with EIIa-Cre transgenic mice, which express the Cre recombinase at all stages of development (30).

RT-PCR analyses

Total RNA was isolated using TRIzol (Invitrogen Life Technologies) and treated with RNase-free DNase I (37°C, 30 min, 10 mM Tris-Cl (pH 8.3), 50 mM KCl, 2 mM MgCl2). Treated RNA (3 µg) was reverse transcribed using random hexanucleotides (31). cDNA reactions were performed in the presence or absence of reverse transcriptase. The µ0 (31), VH (32), and Iµ (31) germline transcripts were assessed by PCR assays as described previously. Amplification products were separated on 2% agarose gels, blotted to ZetaProbe membrane (Amersham), and hybridized to the appropriate radiolabeled probes (see PCR primers and probes). The total amount of input cDNA present in each reaction was standardized using an RT-PCR assay that specifically amplifies {lambda}5 cDNA sequences (33).

For the DSP2/DFL16 RT-PCR assays, 0.5 µg of total RNA was reverse-transcribed for 2 h using Superscript III (Invitrogen Life Technologies) at 50°C, with 100 ng of random hexamers (Amersham Pharmacia). Following reverse transcription, PCR was performed using the following conditions: initial 95°C for 2 min, then 40 cycles consisting of 30 s at 95°C, 30 s at 58°C, 30 s at 72°C, followed by a single 5-min extension at 72°C (for primers, see PCR primers and probes). Amplification products were separated on 3% agarose gels, cloned, and verified by sequence analysis.

PCR assays for IgH rearrangement

DNA extracts were prepared from primary lymphocytes using a cell lysis buffer described previously (31). DNA lysates were prepared at final concentrations of 1 x 103 cells/µl. The relative levels of DH->JH and VH->DHJH rearrangements (31), as well as total DNA content (C{lambda}) (22), were measured using published PCR assays. To detect DQ52->JH3 rearrangements, PCR amplifications were performed for 32 cycles consisting of 1 min at 94°C, 1 min at 56°C, and 1.5 min at 72°C, followed by a single 10-min period at 72°C. For detection of germline, unrearranged IgH loci, a PCR assay was used for 30 cycles consisting of 1 min at 94°C, 1 min at 58°C, and 2 min at 72°C, followed by a single 10-min period at 72°C. Amplification products were separated on 2% agarose gels, blotted to ZetaProbe membrane (Amersham), and hybridized to the appropriate radiolabeled probes (see PCR primers and probes).

PCR primers and probes

Primers and probes used in the PCR assays for DH->JH and VH->DHJH rearrangements (31), C{lambda}, beta-actin (22), VH (32), µ0, Iµ (31), and {lambda}5 (33) have previously been described. Additional primers and probes are as follows. For the DQ52->JH assay: 5'DQ52, 5'-GCGGAGCACCACAGTGCAACTG-3'; 3'J3, 5'-GTCTAGATTCTCACAAGAGTCCGATAGACCCTGG-3'. For the germline IgH PCR assay: 3'J1/1, 5'-GATTGTCACTGTTCCACAGG-3'; 5'JH1/SJ, 5'-GGACTTTGGGCTGGGTTTGG-3'; 3'J1/2 (probe), 5'-ATGGGATCCCTTCTGCAGCATGCAGAGTGTGGC-3'. For the DSP2/DFL16 RT-PCR assays: DFL16.1 forward, 5'-CATACTGGCCAGGGCTTTT-3'; DFL16.1 reverse, 5'-TGGAGCTCAAGAGTCTGCTG-3'; DSP forward, 5'-ACTTGGCAGGGATTTTTGTC-3'; DSP reverse, 5'-TGAAGAGTCTGCTGGGCATA-3'.

FACS analyses

All Abs for cell surface staining were purchased from BD Biosciences. 7AAD was purchased from Molecular Probes (catalog no. A1310). Splenocyte and bone marrow cells from individual, age-matched (6–7 wk) mice were stained with anti-B220-PE (catalog no. 553090) and anti-IgM-FITC (catalog no. 553408) for analysis of total B cell populations, and anti-B220-PE, anti-CD43-biotin (catalog no. 553269) for analysis of precursor B cells. The biotinylated Ab was visualized with streptavidin conjugated to FITC (catalog no. 554057). Flow cytometry was performed on a FACSCalibur instrument (BD Biosciences), and the data were analyzed using CellQuest software. Abs conjugated to magnetic beads for MACS separation were purchased from Miltenyi Biotec.

Isolation of RAG-deficient pro-B cells

Bone marrow cells from RAG-deficient mice harboring either WT, PE+, or PE alleles were incubated with a biotinylated anti-B220 Ab (BD Biosciences, catalog no. 553086) for 15 min at 4°C and followed by streptavidin-conjugated MACS beads (Miltenyi Biotec; catalog no. 130-048-101) for 15 min at 4°C. Purified B220+ cells were then isolated using the autoMACS sorter (Miltenyi Biotec) and total cellular RNA was isolated for RT-PCR assays as described above.

Isolation of pro-B and pre-B cell populations from bone marrow

Bone marrow cells were isolated from WT, PE+, PE, and P+E mice. The cells were incubated with IgM-conjugated MACS beads (Miltenyi Biotec; catalog no. 130-047-301) for 15 min at 4°C and separated using an autoMACS sorter (Miltenyi Biotec). The IgM fraction was incubated with anti-B220-biotin Ab for 15 min at 4°C and then with streptavidin-conjugated MACS beads for 15 min at 4°C. The B220+ cells were isolated using the autoMACS sorter and stained with anti-CD43-PE (catalog no. 553271) and anti-AA4.1-allophycocyanin (eBioscience; catalog no. 17-5892-83). The CD43highAA4.1high population of pro-B cells and the CD43lowAA4.1high population of pre-B cells were sorted on a FACSCalibur instrument (BD Biosciences). The purity of sorted cell populations was >90% as judged by FACS and assays for V{kappa}J{kappa} recombination (data not shown).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Generation and general characterization of knockout mice

To assess the independent contributions of PDQ52 and Eµ in controlling the accessibility of IgH gene segments to recombinase, we generated a vector for homologous recombination that replaces ~300 bp upstream of the DQ52 gene segment with a floxed PGK-Neo cassette (Fig. 1A). The specific deletion in this parental vector originates 15 bp upstream of the 5'DQ52-RSS and spans sequences critical for reported promoter/enhancer activities of PDQ52 (26, 34). Two targeting vectors were prepared: the first contains the entire Eµ region (PE+ vector), and the second lacks 700 bp spanning the core Eµ and its 5' MAR (PE vector) (25, 35). The two targeting vectors were transfected into ES cells and G418-resistant clones were screened for homologous recombination using PCR assays specific for each of the mutant IgH alleles (data not shown). PCR-positive clones were analyzed by Southern blotting to confirm homologous integration of the vectors (Fig. 1B). Chimeric mice were generated by microinjection of targeted ES cell clones into C57BL/6 blastocysts. The chimeras were subsequently mated with C57BL/6 females to obtain germline transmission of the mutant alleles (Fig. 1B). The floxed PGK-Neo cassette was deleted by crossing these animals with mice harboring an EIIA-Cre transgene, which drives expression of Cre recombinase at the earliest stages of embryonic development (30).

Because the functional assembly of IgH loci is a critical component of B lymphocyte development, we first tested whether the PE+ or PE mutations impacted this developmental process. Flow cytometric analysis of homozygous mice harboring the PDQ52 deletion (PE+) revealed normal proportions of splenic B cells (B220+/IgM+) when compared with WT control animals (Fig. 2, top panel). Similarly, B cell populations in the bone marrow of PE+ mice were relatively unaffected by the deletion of the putative promoter element (Fig. 2, middle panel). In sharp contrast, mice homozygous for the PE allele exhibited a 10-fold decrease in the proportion of B220+IgM+ cells, indicating a profound block in B cell development. To further define this developmental defect, we stained bone marrow cells for the CD43 and B220 surface markers. The PE mice possessed a normal complement of B220+CD43+ pro-B cells but were severely deficient in B220+CD43 pre-B cells (Fig. 2, bottom panel). Thus, the promoter/enhancer-deficient mice exhibit a B cell developmental phenotype consistent with that predicted from Eµ knockout studies. Specifically, impaired VH->DHJH rearrangement is expected to block the transition of precursors from the pro-B to the pre-B cell stage of development (24, 25, 36).


Figure 2
View larger version (65K):
[in this window]
[in a new window]
 
FIGURE 2. Impaired B cell development in mice lacking PDQ52 and Eµ. Spleen and bone marrow (BM) cells from 6- to 7-wk-old WT and homozygous mutant mice were analyzed by flow cytometry. Cells were stained with anti-IgM-FITC and anti-B220-PE (top and middle panels) or with anti-CD43-biotin, streptavidin-FITC, and anti-B220-PE (bottom panel). All data were gated for lymphocyte populations. Representative FACS plots from independent analyses of at least four mice for each genotype are shown. The percentages of relevant B cell populations in each tissue are shown in the upper quadrants. No reproducible differences were observed in the cell numbers for spleen or bone marrow from any of the genotypes. Average proportions of B cell populations in each genotype were as follows: BM, CD43+ (pro-B): WT (11.3%), PE+ (12.8%), PE (22.6%); CD43 (pre-B/B): WT (41.3%), PE+ (39.6%), PE (2.2%); IgM+ (B cells): WT (9.5%), PE+ (7.3%), PE (0.6%); spleen, B220+ (B cells): WT (43.1%), PE+ (46.6%), PE (13.1%).

 
Regulation of IgH germline transcription by Eµ

In general, the transcription of germline gene segments is an important correlate of their recombination potential (13, 14, 15, 17). For the IgH locus, two distinct germline transcripts originate from within the DQ52JH region. The µ0 transcript initiates upstream of the DQ52 gene segment and extends through the JH cluster and Cµ coding exons. This primary transcript is processed to generate a spliced µ0 transcript containing the DQ52/JH1 region and Cµ exons (26, 31, 37). The Iµ transcript initiates from multiple sites near Eµ and is spliced from the Iµ mini exon to the Cµ constant region (17, 31) (Fig. 3A). Thus, µ0 and Iµ transcription can be used as an initial readout for chromatin accessibility within the DQ52JH region.


Figure 3
View larger version (56K):
[in this window]
[in a new window]
 
FIGURE 3. IgH germline transcription in pro-B cells. A, Diagram of the germline DHJH cluster from the mouse IgH locus. DQ52 is a single gene segment, whereas DFL16 and DSP2 represent families of segments spread over a 60-kb array. Primer pairs for PCR assays used to measure DFL16 (A/B), DSP2 (C/D), µ0 (E/G), and Iµ (F/G) transcripts are shown as arrows below the cartoon. B, PCR analysis of Iµ and µ0 germline transcription. Pro-B cells (B220+) were purified from RAG-deficient mice containing either WT or mutant (PE+ and PE) IgH alleles. Total RNA from the purified cells was subjected to RT-PCR assays specific for the transcripts indicated at the left of each panel. Total cDNA levels derived from pro-B cells were measured in each sample using a PCR assay for {lambda}5 transcripts. cDNA samples from the RAG-deficient pro-B cell line 63-12, 3T3 fibroblasts, and a derivative of the mature B cell line M12 (5B3) (48 ), were included as positive and negative controls for germline IgH transcription, respectively. The linearity of each assay was confirmed using serial dilutions of cDNA (final six lanes in each panel) derived from the first WT pro-B cell sample (noted by *). PCR amplifications were also performed on RNA samples that were subjected to cDNA reactions lacking reverse transcriptase as a control for genomic DNA contamination (-RT). C, Pro-B cell samples described in B were subjected to PCR assays for germline transcripts derived from the DFL16 and DSP2 families of IgH gene segments. Assay linearity was confirmed with serial 2-fold dilutions of each sample.  

 
To define the function of PDQ52 and Eµ in IgH germline transcription, we first bred the PE+ and PE alleles onto a RAG2-deficient background. The intercrossed offspring (RAG-2–/–) harbor IgH loci that are poised for recombination in pro-B cells but these loci remain frozen in their germline configuration due to the lack of recombinase activity. Thus, RAG-deficient pro-B cells can be used to examine µ0 and Iµ transcription in the absence of IgH rearrangements, which would otherwise delete a portion of the expressed germline sequences. Accordingly, we isolated B220+ bone marrow cells from RAG-deficient mice (pro-B cells), harvested mRNA, and used RT-PCR assays to measure Iµ and µ0 germline transcripts (17, 31). As shown in Fig. 3B, the levels of Iµ and µ0 transcripts were unaffected by deletion of the PDQ52 region. Thus, PDQ52 as defined by reporter gene assays is likely only a portion of the promoter region at the endogenous IgH locus. Our data indicate that sequences lying upstream of PDQ52 must also possess promoter activity.

In contrast to the single mutation, dual deletion of PDQ52 and Eµ led to substantial reductions in the steady-state levels of both Iµ and µ0 germline transcripts (Fig. 3B, top and middle panels). Control experiments verified that purified cells from each IgH genotype expressed similar levels of the pro-B cell-specific {lambda}5 gene (Fig. 3B, bottom panel). Similar results were obtained with pro-B cells from mice lacking only the core Eµ element (38), indicating a dominant role for the enhancer in this transcriptional defect at the DQ52JH cluster. We conclude that the PDQ52 deletion in the PE allele is functionally neutral; the primary phenotypes displayed at this mutant IgH locus are largely attributable to the accompanying enhancer deletion.

To further define the effect of Eµ on chromatin accessibility throughout the entire DHJH cluster, we measured germline transcripts from the DFL16 and DSP2 gene families, which lie from 10 to 80 kb upstream of the DQ52 segment (Fig. 4) (39). Consistent with µ0 and Iµ expression data, DFL16 and DSP2 germline transcription was unaffected by the PDQ52 deletion (Fig. 3C). However, mice homozygous for the PE mutation exhibited at least a 5-fold reduction in steady-state levels of the DFL16 and DSP2 germline transcripts. Together, these results indicate that efficient germline expression of the entire DHJH cluster is regulated by the IgH intronic enhancer and further suggest that Eµ is important for controlling long-range chromatin accessibility of this region within the IgH locus.


Figure 4
View larger version (40K):
[in this window]
[in a new window]
 
FIGURE 4. Inhibition of DH->JH recombination in pro-B cells from Eµ-deficient mice. A, Schematic depiction of PCR assays for DH->JH rearrangement (top). Arrows denote the relative position of PCR primers (31 ). Purified pro-B cells from the indicated IgH genotypes were subjected to the DH->JH PCR assay, and the results are shown at the bottom. Samples from two experiments using sorted cells from independent mice are shown for each genotype. Amplification products corresponding to germline IgH alleles (GL), as well as DHJH1 (J1), DHJH2 (J2), and DHJH3 (J3) rearrangements are denoted at the left. Control PCR assays for total DNA content (C{lambda}) are shown in the bottom panel. The linearity of each assay was confirmed using serial dilutions of unsorted WT bone marrow (BM) and WT pro-B cells shown in lane 1 (1/2, 1/5, and 1/10). Genomic DNA from the RAG-deficient pro-B cell line 63-12 was included as a negative control. B, Diagrammatic representation of the PCR assay for measuring retention of germline IgH alleles (top). Pro-B cell DNA from WT, PE+, PE, and P+E mice were analyzed for levels of germline IgH alleles (GL) and total DNA (C{lambda}). Generation of P+E mice was described in Ref.38 . Titrations were performed on DNA from unsorted WT bone marrow (BM) and from the RAG-deficient pro-B cell line 63-12 (final eight lanes).  

 
Eµ is required for efficient DHJH recombination

Prior analyses of IgH gene assembly in Eµ knockout mice were performed on mature B cells that were heterozygous for an enhancer-deficient allele (Eµ+/–). These studies suggested that deletion of Eµ has only a modest effect on DH->JH recombination (≤2-fold) (24, 25). Because these experiments used endpoint B cells, the possibility remained that Eµ may have a more profound impact on the initiation of DH->JH recombination in pro-B cells. Specifically, the DHJH cluster may continue to rearrange in later stages of B cell development that express V(D)J recombinase (i.e., pre-B and emerging B cells). This scenario would also explain the profound block in VH->DJH rearrangements observed for Eµ+/– B cells, because allelic exclusion mechanisms would suppress this process in pre-B and emerging B cells.

To assess whether Eµ or PDQ52 function to regulate DH->JH recombination in pro-B cells, we sorted this precursor population from the bone marrows of WT, PE+, and PE mice using flow cytometry (see Materials and Methods). Genomic DNA from the purified cells was subjected to PCR assays using a degenerate set of oligonucleotide primers that recognize sequences directly 5' of 12 DH gene segments (Fig. 4A, primer A) (31), a primer that recognizes the 5' DQ52-RSS (primer B), and a downstream primer specific for a sequence 3' to the JH3 gene segment (primer C). Using this assay, impaired DH->JH recombination would be manifest as both a reduction in the levels of detectable rearrangement products and as an enhanced retention of the germline IgH allele. As shown in Fig. 4A, deletion of PDQ52 had no detectable effect on the loss of germline IgH alleles and exhibited normal levels of DH->JH rearrangement when compared with WT pro-B cells. Thus, similar to germline transcription, PDQ52 is dispensable for normal DH->JH rearrangement. In contrast, dual deletion of PDQ52 and Eµ resulted in a dramatic retention of germline IgH alleles, indicating a profound block in DH->JH rearrangement. Similar data were obtained using PCR assays that specifically detect rearrangements involving only the DQ52 gene segment or that monitor recombination of all four JH segments (data not shown).

To more accurately measure the effects of these cis-acting elements on the efficiency of DH->JH recombination, we performed a second PCR assay, which detects only the retention of germline IgH loci in DNA from purified pro-B cells. Data from these analyses were normalized for total DNA content using a separate PCR assay specific for germline sequences in the Ig{lambda} constant region exon (C{lambda}) (22). As shown in Fig. 4B, pro-B cells from WT and PE+ mice exhibited a comparable loss of germline IgH alleles, indicating that IgH rearrangements were unaffected by the PDQ52 deletion. In contrast, we observed a profound increase in the retention of germline IgH alleles in pro-B cells harboring the PE mutation. When normalized for DNA content (C{lambda}), semiquantitative analysis of these PCR data indicated an increase in the retention of germline IgH loci in PE cells (IgH:C{lambda} ratio ~1.7) that ranged from 5- to 10-fold higher when compared with normalized signals in WT cells from C57BL/6 littermates (IgH:C{lambda} ratio ~0.25). We also examined pro-B cell samples from mice that harbored a deletion of only the Eµ element (P+E) (38) and its corresponding WT littermates (129 strain). Unlike the PE mutation, which lacked Eµ and its 5' MARs, only the core Eµ element was deleted in the P+E mutation. Pro-B cells from the WT 129 strain retained higher levels of germline IgH alleles compared with their C57BL/6 counterparts (IgH:C{lambda} ratios ~1.1 and ~0.25, respectively). However, the single Eµ knockout displayed an ~5-fold increase in retention of their germline IgH alleles relative to the 129 pro-B cells (IgH:C{lambda} ratio ~4.8). Together, these data indicate that Eµ plays a more significant role in the regulation of DH->JH recombination than was previously appreciated.

Pro-B cells purified from adult bone marrow are a mixed population of cells with regards to the genetic configuration of the IgH locus. The cells used in our analyses undergo both DH->JH and VH->DJH recombination. One complicating factor we considered is that rearrangements involving VH segments will eliminate annealing sites for primers used in DH->JH rearrangement assays. In contrast to pro-B cells, a significant portion of thymocytes contain DH->JH rearrangements but are blocked from completing VH->DJH recombination (40). Thus, thymocytes offer an independent cell system to directly test the effects of PDQ52 and Eµ on DH->JH rearrangement efficiencies without the complications associated with VH->DJH recombination. As shown in Fig. 5, DH->JH rearrangement was unaffected in thymocytes from PE+ mice, which lack only the PDQ52 region. Dual deletion of PDQ52 and Eµ or a single deletion of only the core enhancer both led to a dramatic reduction in the levels of DH->JH rearrangement detected in thymocytes (>20-fold decrease). These findings further demonstrate that, although PDQ52 is dispensable, Eµ plays an important role in controlling both germline transcription and recombination of the DHJH cluster.


Figure 5
View larger version (41K):
[in this window]
[in a new window]
 
FIGURE 5. Eµ deletions completely inhibit DHJH rearrangement in thymocytes. Whole thymocyte DNAs from the indicated IgH genotypes were subjected to PCR assays for either DQ52->JH (upper panel) or overall DH->JH recombination (lower panel). The relative positions of amplification products corresponding to germline IgH alleles (GL), or alleles containing DHJH1 (J1), DHJH2 (J2) or DHJH3 (J3) rearrangements are shown at the left. Each set shows a serial dilution of one sample (1/2, 1/5, and 1/10). Identical results were obtained using thymocyte DNA from multiple mice of each genotype (data not shown). Refer to Fig. 4 legend for additional details.

 
Germline VH transcription is unaffected by deletion of Eµ

Prior studies using mature B cells from Eµ+/– animals indicated that deletion of the intronic enhancer severely impairs VH->DHJH rearrangement (24, 25), suggesting that VH gene segments are either directly or indirectly regulated by Eµ. However, our new data derived from pro-B cells suggest that the block in VH->DHJH rearrangement may be a secondary effect resulting from reduced DH->JH recombination. To address the possibility that the enhancer is directly regulating VH accessibility, we studied the effects of PDQ52 and Eµ deletions on VH rearrangement and germline transcription. We first used a published PCR assay to examine VH->DHJH rearrangements in sorted pro-B cells (31) (Fig. 6A). Using this assay, we found that PDQ52 is dispensable for VH->DHJH rearrangement. In keeping with prior Eµ knockout studies, dual deletion of PDQ52 and Eµ resulted in a marked reduction of VH->DHJH rearrangement. Similar results were obtained from PCR assays using primers specific for the rearrangement of three major VH families (VHJ558, VHQ52, and VH7183), which are spread throughout the entire VH cluster (data not shown). Thus, inhibition of VH->DHJH recombination in these animals is not due to a regional loss of recombinase accessibility at only a subset of VH gene segments.


Figure 6
View larger version (42K):
[in this window]
[in a new window]
 
FIGURE 6. Deletion of the intronic enhancer affects VH->DHJH recombination independent of germline VH transcription. A, Schematic depiction of PCR assays for VH->DHJH rearrangement and VH germline transcription (top). For VH->DHJH recombination, a mixture of degenerate primers that recognize the three major VH families (VH558, VHQ52, and VH7183) were used in conjunction with a primer specific for the JH3 gene segment (31 ). The relative position of amplification products corresponding to VHDHJH1 (J1), VHDHJH2 (J2), and VHDHJH3 (J3) rearrangements are indicated at the left. Controls and sample titrations of the first WT sample are described in the legend for Fig. 4. B, Germline VH transcription. Total cellular RNA was isolated from B220+ bone marrow cells (pro-B) from RAG-deficient mice that were homozygous for the indicated IgH alleles. The RNA was subjected to RT-PCR assays for VH germline transcription using degenerate primers for three VH gene families (32 ). PCR products were blotted and hybridized with radiolabeled oligonucleotide probes that recognize specific sequences in each of these VH families. Total cDNA levels were controlled in each sample using a PCR assay for the pro-B cell-specific {lambda}5 transcript. Refer to Fig. 3 legend for a description of additional controls. The linearity of each assay was confirmed using serial dilutions of cDNA (final five lanes in each panel) derived from the first sample denoted by *.

 
As an independent test for whether Eµ regulates chromatin accessibility at VH gene segments, we measured germline transcription of the three major VH families in pro-B cells from RAG-deficient mice (Fig. 6A) (32). Although the steady-state expression levels vary between mice, germline VH transcripts were unaffected by deletion of either the PDQ52 or the Eµ element (Fig. 6). This finding differs significantly from the substantial decrease in germline DH transcription observed in these cells (Fig. 3) and strongly suggests that Eµ does not directly regulate accessibility of the VH region. Instead, our data are consistent with a model for IgH regulation in which reduced VH->DJH recombination in Eµ-deficient mice largely results from a primary block in DH->JH rearrangements.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
The targeted deletion of transcriptional promoters and enhancers at most Ag receptor loci represses chromatin accessibility at linked gene segments and blocks their assembly by V(D)J recombinase (18, 19, 20, 21). In contrast, deletion of the IgH intronic enhancer (Eµ) had a minimal impact on primary DH->JH rearrangements, but significantly reduced levels of VH->DHJH recombination when assessed in peripheral B cells (24, 25). One plausible explanation for this phenotype is the existence of an unidentified control element near the DHJH cluster that can compensate for the loss of Eµ. A prime candidate for the compensatory element is PDQ52, which has promoter/enhancer activity in reporter assays and, together with Eµ, is the only DNase hypersensitive region within the DHJH cluster (26, 41). An alternative explanation is that Eµ may have a more substantial role in the regulation of DH->JH recombination but continued rearrangement of the mutant allele during B cell development masks its full impact when assessed in peripheral B cells (25).

To test both of these possibilities, we generated mice with targeted deletions of PDQ52 and Eµ. Our experimental results demonstrate that: 1) the PDQ52 element defined by reporter assays has minimal impact on IgH germline transcription and rearrangement; 2) when analyzed in pro-B cells or thymocytes, deletion of Eµ significantly impairs DH->JH recombination; 3) Eµ plays an important role in the regulation of germline transcripts throughout the DHJH cluster; and 4) Eµ is dispensable for transcription of germline VH gene segments. Together, these findings indicate that Eµ is an important component of the mechanisms controlling recombinase accessibility at the DHJH cluster in pro-B cells. The defect in VH->DHJH recombination is likely a downstream consequence of impaired DH->JH recombination at Eµ-deficient alleles (see below).

A surprising result from our knockout studies is that deletion of the previously defined PDQ52 element has no effect on germline transcription of the DHJH cluster (Fig. 3). In this regard, an independent deletion of the DQ52 gene segment and a smaller portion of its 5' region also retained germline DHJH transcription (28). These findings indicate that additional promoter and/or enhancer activity must reside upstream from "PDQ52" (26). Additional studies are required to identify these novel elements and to determine their role in the regulation of chromatin accessibility at the DHJH cluster. We conclude that defects in germline transcription and DH->JH recombination arising from the dual PE mutation are largely or solely due to the absence of Eµ rather than PDQ52.

To directly assess the effects of Eµ deletions on primary DHJH recombination, we analyzed purified pro-B cells, the developmental stage that initiates IgH gene assembly. Pro-B cells from enhancer-deficient mice exhibit at least a 5- to 10-fold increase in their retention of germline IgH alleles when compared with WT counterparts (Fig. 4B). These data are fully consistent with a contemporaneous study showing that B cell hybridomas from mice heterozygous for a deletion of the core Eµ element have an elevated retention of the germline IgH configuration only at mutant alleles (38). When normalized for DNA content and compared with its corresponding WT strain, pro-B cells from these P+E mice had slightly lower levels of germline IgH alleles than pro-B cells harboring the PE mutation (Fig. 4B and data not shown). Thus, PDQ52 may possess a modest compensatory function for regulation of the DHJH cluster in the absence of Eµ. However, this interpretation is difficult to resolve for two reasons: 1) the PE allele harbors a more extensive deletion of the intronic enhancer, which includes the 5' MARs; and 2) the PE+ and P+E alleles were bred into distinct genetic backgrounds (C57BL/6 and 129, respectively).

Notwithstanding these uncertainties, a dominant role for Eµ in the regulation of accessibility at the DHJH cluster is supported by additional evidence emerging from our studies. Deletion of the enhancer together with PDQ52 affects germline transcription of DH gene segments throughout the entire cluster, which spans nearly 80 kb (Fig. 3). Moreover, DH->JH rearrangement is completely blocked in thymocytes from Eµ-deficient mice (Fig. 5). Collectively, these results argue that Eµ serves as a long-range control element to exert a positive influence on efficient recombination throughout the entire DHJH cluster. This influence is critical to facilitate efficient DH->JH recombination and to guide subsequent stages of B cell development.

Consistent with prior studies of mice containing B cells that were heterozygous for Eµ-deleted alleles, we observe a profound block in VH->DHJH recombination in pro-B cells from the PE mice. A possible interpretation of these results is that Eµ directly regulates accessibility of VH gene segments, which are located at least 100 kb upstream from this enhancer. However, we find that germline transcription of the VH cluster is unaffected by the enhancer deletion (Fig. 6). Collectively, our studies support an alternative interpretation–the block in VH->DJH rearrangement is largely a secondary defect stemming from a substantial reduction in the formation of substrates containing a requisite DH->JH junction. This interpretation is fully consistent with data from enhancer deletions at the TCRbeta locus, which inhibit Vbeta->DJbeta rearrangement as a consequence of a loss in chromatin accessibility at the DbetaJbeta but not at the Vbeta clusters (42).

Although the primary defect in Eµ-deficient pro-B cells is inhibition of DH->JH recombination, the reductions in subsequent VH->DJH rearrangement are even more pronounced. We hypothesize that the further reduction in VH->DHJH junctions may be a consequence of the "stalling-out" that must occur in B cell development as a result of Eµ deletions. Precursor cells stuck at the pro-B stage may continue to accumulate DH->JH joins at a lower rate, but given the limited lifespan of these cells, the remaining window of time for VH->DHJH recombination may be extremely narrow. Consistent with this possibility, we analyzed IgH rearrangements in precursor B cells from fetal liver, which undergo a synchronous wave of either DH->JH (day 14) or VH->DHJH recombination (day 16). In these cells, we find that DH->JH and VH->DHJH recombination are compromised to an equal extent when Eµ is deleted (data not shown). Despite these findings, we cannot rule out an auxiliary role for Eµ in the complex mechanisms that regulate efficient VH->DHJH recombination, including contraction of the IgH locus or changes in chromatin modifications at VH gene segments (41, 43, 44).

Although deletion of Eµ clearly affects chromatin accessibility throughout the DHJH cluster, these gene segments continue to rearrange with a modest efficiency. The residual recombination at Eµ-deficient alleles indicates the existence of additional cis-elements involved in the control of DHJH accessibility. Our findings strongly suggest that the function of this unidentified element must be restricted to pro-B cells because DH->JH recombination is completely abolished in Eµ-deficient thymocytes (Fig. 5). Based on prior studies, several candidates can be envisioned for the additional regulatory element(s): 1) The region upstream of PDQ52. The retention of germline DHJH transcripts in PE+ mice strongly suggests additional promoter activity within this region. Analogous to the TCRbeta locus (45), deletion of the complete germline promoter may abrogate DH->JH rearrangement. 2) The 3' C{alpha} region contains four enhancers that can regulate promoters over extremely large distances (>200 kb) (46). This global effect may partially compensate for the loss of Eµ function, leading to a partial activation of germline transcription and DHJH recombination. 3) A defined region between the C{delta} and C{gamma}3 coding exons (E{delta}-{gamma}3) in the human IgH locus has been shown to potentiate transcription from transgenic reporter genes in mouse precursor B cells. This putative enhancer, which may have a murine homolog, also functions cooperatively with Eµ in reporter assays (47). The mice reported in the present study, which harbor deletions in the two known DHJH regulatory elements, will be important reagents for deciphering the complex interplay of promoters and enhancers that activate IgH gene assembly and trigger the B cell developmental program.


    Acknowledgments
 
We thank C. Edson and O. Osipovich for their contributions to the initial stages of this project. We are also grateful to F. Alt and colleagues for providing core Eµ knockout animals and sharing unpublished data.


    Disclosures
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
The authors have no financial conflict of interest.


    Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the National Institutes of Health (P01 HL68744 and CA100905 to E.M.O.; T32 CA09385 to R.A.) and a Cancer Center Support Grant (P30 CA68485, Vanderbilt-Ingram Cancer Center). Back

2 Address correspondence and reprint requests to Dr. Eugene M. Oltz, Department of Microbiology/Immunology, Vanderbilt University Medical School, Nashville, TN 37232. E-mail address: eugene.oltz{at}vanderbilt.edu Back

3 Abbreviations used in this paper: RSS, recombination signal sequence; MAR, matrix attachment region; ES, embryonic stem; WT, wild type. Back

Received for publication September 2, 2005. Accepted for publication December 1, 2005.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Hesslein, D. G., D. G. Schatz. 2001. Factors and forces controlling V(D)J recombination. Adv. Immunol. 78: 169-232. [Medline]
  2. Bassing, C. H., W. Swat, F. W. Alt. 2002. The mechanism and regulation of chromosomal V(D)J recombination. Cell 109: (Suppl.):S45-S55. [Medline]
  3. Roth, D. B., S. Y. Roth. 2000. Unequal access: regulating V(D)J recombination through chromatin remodeling. Cell 103: 699-702. [Medline]
  4. Oltz, E. M.. 2001. Regulation of antigen receptor gene assembly in lymphocytes. Immunol. Res. 23: 121-133. [Medline]
  5. Oettinger, M. A., D. G. Schatz, C. Gorka, D. Baltimore. 1990. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248: 1517-1523. [Abstract/Free Full Text]
  6. Schatz, D. G., M. A. Oettinger, D. Baltimore. 1989. The V(D)J recombination activating gene, RAG-1. Cell 59: 1035-1048. [Medline]
  7. Dudley, D. D., J. Chaudhuri, C. H. Bassing, F. W. Alt. 2005. Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences. Adv. Immunol. 86: 43-112. [Medline]
  8. Fugmann, S. D., A. I. Lee, P. E. Shockett, I. J. Villey, D. G. Schatz. 2000. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu. Rev. Immunol. 18: 495-527. [Medline]
  9. Hardy, R. R., K. Hayakawa. 2001. B cell development pathways. Annu. Rev. Immunol. 19: 595-621. [Medline]
  10. Alt, F. W., G. D. Yancopoulos, T. K. Blackwell, C. Wood, E. Thomas, M. Boss, R. Coffman, N. Rosenberg, S. Tonegawa, D. Baltimore. 1984. Ordered rearrangement of immunoglobulin heavy chain variable region segments. EMBO J. 3: 1209-1219. [Medline]
  11. Chevillard, C., J. Ozaki, C. D. Herring, R. Riblet. 2002. A three-megabase yeast artificial chromosome contig spanning the C57BL mouse IgH locus. J. Immunol. 168: 5659-5666. [Abstract/Free Full Text]
  12. Stanhope-Baker, P., K. M. Hudson, A. L. Shaffer, A. Constantinescu, M. S. Schlissel. 1996. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell 85: 887-897. [Medline]
  13. Alt, F. W., E. M. Oltz, F. Young, J. Gorman, G. Taccioli, J. Chen. 1992. VDJ recombination. Immunol. Today 13: 306-314. [Medline]
  14. Sleckman, B. P., J. R. Gorman, F. W. Alt. 1996. Accessibility control of antigen-receptor variable-region gene assembly: role of cis-acting elements. Annu. Rev. Immunol. 14: 459-481. [Medline]
  15. Yancopoulos, G. D., F. W. Alt. 1985. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell 40: 271-281. [Medline]
  16. Krangel, M. S.. 2003. Gene segment selection in V(D)J recombination: accessibility and beyond. Nat. Immunol. 4: 624-630. [Medline]
  17. Lennon, G. G., R. P. Perry. 1985. C mu-containing transcripts initiate heterogeneously within the IgH enhancer region and contain a novel 5'-nontranslatable exon. Nature 318: 475-478. [Medline]
  18. Bouvier, G., F. Watrin, M. Naspetti, C. Verthuy, P. Naquet, P. Ferrier. 1996. Deletion of the mouse T-cell receptor beta gene enhancer blocks {alpha}beta T-cell development. Proc. Natl. Acad. Sci. USA 93: 7877-7881. [Abstract/Free Full Text]
  19. Bories, J. C., J. Demengeot, L. Davidson, F. W. Alt. 1996. Gene-targeted deletion and replacement mutations of the T-cell receptor beta-chain enhancer: the role of enhancer elements in controlling V(D)J recombination accessibility. Proc. Natl. Acad. Sci. USA 93: 7871-7876. [Abstract/Free Full Text]
  20. Sleckman, B. P., C. G. Bardon, R. Ferrini, L. Davidson, F. W. Alt. 1997. Function of the TCR {alpha} enhancer in {alpha}beta and {gamma}{delta} T cells. Immunity 7: 505-515. [Medline]
  21. Xu, Y., L. Davidson, F. W. Alt, D. Baltimore. 1996. Deletion of the Ig {kappa} light chain intronic enhancer/matrix attachment region impairs but does not abolish V{kappa}J{kappa} rearrangement. Immunity 4: 377-385. [Medline]
  22. Sikes, M. L., C. C. Suarez, E. M. Oltz. 1999. Regulation of V(D)J recombination by transcriptional promoters. Mol. Cell. Biol. 19: 2773-2781. [Abstract/Free Full Text]
  23. Whitehurst, C. E., S. Chattopadhyay, J. Chen. 1999. Control of V(D)J recombinational accessibility of the D beta 1 gene segment at the TCR beta locus by a germline promoter. Immunity 10: 313-322. [Medline]
  24. Serwe, M., F. Sablitzky. 1993. V(D)J recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer. EMBO J. 12: 2321-2327. [Medline]
  25. Sakai, E., A. Bottaro, L. Davidson, B. P. Sleckman, F. W. Alt. 1999. Recombination and transcription of the endogenous Ig heavy chain locus is effected by the Ig heavy chain intronic enhancer core region in the absence of the matrix attachment regions. Proc. Natl. Acad. Sci. USA 96: 1526-1531. [Abstract/Free Full Text]
  26. Kottmann, A. H., B. Zevnik, M. Welte, P. J. Nielsen, G. Kohler. 1994. A second promoter and enhancer element within the immunoglobulin heavy chain locus. Eur. J. Immunol. 24: 817-821. [Medline]
  27. Chowdhury, D., R. Sen. 2001. Stepwise activation of the immunoglobulin mu heavy chain gene locus. EMBO J. 20: 6394-6403. [Medline]
  28. Nitschke, L., J. Kestler, T. Tallone, S. Pelkonen, J. Pelkonen. 2001. Deletion of the DQ52 element within the Ig heavy chain locus leads to a selective reduction in VDJ recombination and altered D gene usage. J. Immunol. 166: 2540-2552. [Abstract/Free Full Text]
  29. Cao, S., H. Bendall, G. G. Hicks, A. Nashabi, H. Sakano, Y. Shinkai, M. Gariglio, E. M. Oltz, H. E. Ruley. 2003. The high-mobility-group box protein SSRP1/T160 is essential for cell viability in day 3.5 mouse embryos. Mol. Cell. Biol. 23: 5301-5307. [Abstract/Free Full Text]
  30. Lakso, M., J. G. Pichel, J. R. Gorman, B. Sauer, Y. Okamoto, E. Lee, F. W. Alt, H. Westphal. 1996. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 93: 5860-5865. [Abstract/Free Full Text]
  31. Schlissel, M. S., L. M. Corcoran, D. Baltimore. 1991. Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription. J. Exp. Med. 173: 711-720. [Abstract/Free Full Text]
  32. Angelin-Duclos, C., K. Calame. 1998. Evidence that immunoglobulin VH-DJ recombination does not require germ line transcription of the recombining variable gene segment. Mol. Cell. Biol. 18: 6253-6264. [Abstract/Free Full Text]
  33. Shimizu, T., C. Mundt, S. Licence, F. Melchers, I. L. Martensson. 2002. VpreB1/VpreB2/{lambda} 5 triple-deficient mice show impaired B cell development but functional allelic exclusion of the IgH locus. J. Immunol. 168: 6286-6293. [Abstract/Free Full Text]
  34. Kottmann, A. H., C. Brack, H. Eibel, G. Kohler. 1992. A survey of protein-DNA interaction sites within the murine immunoglobulin heavy chain locus reveals a particularly complex pattern around the DQ52 element. Eur. J. Immunol. 22: 2113-2120. [Medline]
  35. Cockerill, P. N., M. H. Yuen, W. T. Garrard. 1987. The enhancer of the immunoglobulin heavy chain locus is flanked by presumptive chromosomal loop anchorage elements. J. Biol. Chem. 262: 5394-5397. [Abstract/Free Full Text]
  36. Chen, J., F. Young, A. Bottaro, V. Stewart, R. K. Smith, F. W. Alt. 1993. Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus. EMBO J. 12: 4635-4645. [Medline]
  37. Thompson, A., E. Timmers, R. K. Schuurman, R. W. Hendriks. 1995. Immunoglobulin heavy chain germ-line JH-C µ transcription in human precursor B lymphocytes initiates in a unique region upstream of DQ52. Eur. J. Immunol. 25: 257-261. [Medline]
  38. Perlot, T., F. W. Alt, C. H. Bassing, H. Suh, E. Pinaud. 2005. Elucidation of IgH intronic enhancer functions via germ-line deletion. Proc. Natl. Acad. Sci. USA 102: 14362-14367. [Abstract/Free Full Text]
  39. Yancopoulos, G. D., F. W. Alt. 1986. Regulation of the assembly and expression of variable-region genes. Annu. Rev. Immunol. 4: 339-368. [Medline]
  40. Born, W., J. White, J. Kappler, P. Marrack. 1988. Rearrangement of IgH genes in normal thymocyte development. J. Immunol. 140: 3228-3232. [Abstract]
  41. Chowdhury, D., R. Sen. 2003. Transient IL-7/IL-7R signaling provides a mechanism for feedback inhibition of immunoglobulin heavy chain gene rearrangements. Immunity 18: 229-241. [Medline]
  42. Mathieu, N., W. M. Hempel, S. Spicuglia, C. Verthuy, P. Ferrier. 2000. Chromatin remodeling by the T cell receptor (TCR)-beta gene enhancer during early T cell development: implications for the control of TCR-beta locus recombination. J. Exp. Med. 192: 625-636. [Abstract/Free Full Text]
  43. Kosak, S. T., J. A. Skok, K. L. Medina, R. Riblet, M. M. Le Beau, A. G. Fisher, H. Singh. 2002. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296: 158-162. [Abstract/Free Full Text]
  44. Roldan, E., M. Fuxa, W. Chong, D. Martinez, M. Novatchkova, M. Busslinger, J. A. Skok. 2005. Locus ‘decontraction’ and centromeric recruitment contribute to allelic exclusion of the immunoglobulin heavy-chain gene. Nat. Immunol. 6: 31-41. [Medline]
  45. Whitehurst, C. E., M. S. Schlissel, J. Chen. 2000. Deletion of germline promoter PD beta 1 from the TCR beta locus causes hypermethylation that impairs D beta 1 recombination by multiple mechanisms. Immunity 13: 703-714. [Medline]
  46. Cogne, M., R. Lansford, A. Bottaro, J. Zhang, J. Gorman, F. Young, H. L. Cheng, F. W. Alt. 1994. A class switch control region at the 3' end of the immunoglobulin heavy chain locus. Cell 77: 737-747. [Medline]
  47. Mundt, C. A., I. C. Nicholson, X. Zou, A. V. Popov, C. Ayling, M. Bruggemann. 2001. Novel control motif cluster in the IgH {delta}-{gamma}3 interval exhibits B cell-specific enhancer function in early development. J. Immunol. 166: 3315-3323. [Abstract/Free Full Text]
  48. Sikes, M. L., E. M. Oltz. 1999. An inducible cell model for studies of V(D)J recombinational control. J. Immunol. Methods 224: 25-29. [Medline]



This article has been cited by other articles:


Home page
J. Immunol.Home page
I. Achour, P. Cavelier, M. Tichit, C. Bouchier, P. Lafaye, and F. Rougeon
Tetrameric and Homodimeric Camelid IgGs Originate from the Same IgH Locus
J. Immunol., August 1, 2008; 181(3): 2001 - 2009.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. R. Thomas, H. Miyashita, R. M. Cobb, S. Pierce, M. Tachibana, E. Hobeika, M. Reth, Y. Shinkai, and E. M. Oltz
Functional Analysis of Histone Methyltransferase G9a in B and T Lymphocytes
J. Immunol., July 1, 2008; 181(1): 485 - 493.
[Abstract] [Full Text] [PDF]